BioMarin Pharmaceutical
BMRN
Last Price
52 Week Range
$50.76 - $69.87
Next Earnings Date
May 07 2026 (Estimate)
Next Earnings Date
May 07 2026 (Est.)
Last Price
BioMarin Pharmaceutical SEC Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
BioMarin Pharmaceutical Inc. | 8-K | March 16, 2026 | |
BioMarin Pharmaceutical Inc. | 10-K | February 26, 2026 | |
BioMarin Pharmaceutical Inc. | 8-K | February 23, 2026 | |
BioMarin Pharmaceutical Inc. | 8-K | February 12, 2026 | |
BioMarin Pharmaceutical Inc. | 8-K | January 29, 2026 | |
BioMarin Pharmaceutical Inc. | 8-K | January 26, 2026 | |
BioMarin Pharmaceutical Inc. | 8-K | January 12, 2026 | |
BioMarin Pharmaceutical Inc. | 8-K | December 22, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | December 19, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | December 17, 2025 | |
BioMarin Pharmaceutical Inc. | 10-Q | October 28, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | October 27, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | October 7, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | August 11, 2025 | |
BioMarin Pharmaceutical Inc. | 10-Q | August 5, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | August 4, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | August 1, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | May 22, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | May 16, 2025 | |
BioMarin Pharmaceutical Inc. | 10-Q | May 2, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | May 1, 2025 | |
BioMarin Pharmaceutical Inc. | DEF 14A | April 8, 2025 | |
BioMarin Pharmaceutical Inc. | DEFA14A | April 8, 2025 | |
BioMarin Pharmaceutical Inc. | ARS | April 8, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | March 3, 2025 | |
BioMarin Pharmaceutical Inc. | 10-K | February 24, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | February 24, 2025 | |
BioMarin Pharmaceutical Inc. | 8-K | February 19, 2025 | |
BioMarin Pharmaceutical Inc. | 10-Q | October 31, 2024 | |
BioMarin Pharmaceutical Inc. | 8-K | October 29, 2024 |
Load More...
Gainify
Features
Platform
Resources
Learn
Socials
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.